Clinical trial Recruiting at 2 sites Observational Ages 18 to 94 Women only

ATUSA 3D automated breast ultrasound for suspicious breast lesions

Official title: ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE), a Case Collection Registry for 3D Breast Automated Ultrasound Using ATUSA System as Well as Other Breast Imaging Modalities.

Run by iSono Health, Inc. · NCT07505797 · Data updated 2026-11-12

This study will test whether the ATUSA 3D automated breast ultrasound system can produce high-quality images that match biopsy results in women with BI-RADS 4 or 5 breast findings.

More Breast Cancer trials

Quick facts

Study typeObservational
Ages18 Years to 94 Years
SexWomen only
Enrollment800 (estimated)
SponsoriSono Health, Inc.
Industry-sponsored
Drugs / interventionsradiation
Locations2 sites (Sacramento, California and 1 other locations)
StatusRecruiting
StartedDecember 16, 2025
Main results expectedAugust 2027
Study endsAugust 2027
Registry record updatedSeptember 17, 2026
Trial IDNCT07505797 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18 to 94 with a recent BI-RADS 4 or 5 breast imaging result who are scheduled for biopsy and can attend imaging and follow-up visits are ideal candidates.

Probably not a fit

Patients who are pregnant or breastfeeding, have incompatible breast anatomy or recent breast surgery/treatment, active skin lesions, MRI-incompatible implants, or a prior bilateral mastectomy are unlikely to benefit or may be ineligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

AUDIBLE is a multi-site observational registry in the United States collecting 3D automated breast ultrasound images using the iSono Health ATUSA system from up to 800 female patients with BI-RADS 4 or 5 findings referred for biopsy. Participants will undergo ATUSA imaging in addition to their standard-of-care imaging and the study will gather multi-modality images, medical record data, and biopsy histopathology. The protocol examines image quality, reproducibility, and how ATUSA findings correlate with radiologist-assigned BI-RADS categories and histopathology, and follows a subset of patients receiving neoadjuvant therapy longitudinally. Collected data will be centralized to support device validation and a comprehensive imaging registry.

Why it matters

Potential benefit: If successful, ATUSA could provide more consistent, reproducible ultrasound images that better correspond to biopsy results and help clinicians make more accurate diagnostic decisions, especially in patients with dense breasts.

How similar studies have gone: Automated 3D breast ultrasound systems (ABUS) have shown promising results, particularly for lesion detection in dense breasts, but device-specific validation data for ATUSA remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Provide written informed consent through a signed and dated consent form.
2. Demonstrate commitment to complete all study requirements and maintain availability for the full study duration.
3. Be female, aged 18 to 94 years (inclusive).
4. Have a recent BI-RADS® 4 or 5 classification confirmed through breast imaging and medical records.

Exclusion Criteria:

1. Active skin lesions (open wounds or unhealed sores) on either breast.
2. Implanted medical devices (pacemakers, defibrillators) or MRI incompatible materials that cannot be temporarily removed.
3. Current pregnancy or breastfeeding status (self-reported).Documented hypersensitivity to silicone or gadolinium-based contrast agents.
4. Previous bilateral mastectomy.
5. Physical inability to maintain a supine position for 30 minutes.
6. Breast anatomy incompatible with ATUSA device specifications.
7. Recent (within 12 months) breast surgery or cancer treatment.
8. Negative findings on diagnostic ultrasound examination within 30 days of Screening, but prior to initiating study required procedures.
9. Any medical or psychological condition that, in the Principal Investigator's judgment, could affect study participation or data integrity.

Where it's running

  • UC Davis
    Sacramento, California, United States
    Recruiting
  • Cypress Innovative Breast Care Center
    Cypress, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.